BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19022927)

  • 1. A surprising hyperpigmentation of the gums and tongue.
    Dell'Isola S; Ialungo AM; Starnini G; Roselli P; Ghittoni G; Caturelli E
    Gut; 2008 Dec; 57(12):1697, 1727. PubMed ID: 19022927
    [No Abstract]   [Full Text] [Related]  

  • 2. What caused this lingual hyperpigmentation in a patient with chronic hepatitis C?
    Radha Krishna Y; Itha S
    Liver Int; 2010 Mar; 30(3):416. PubMed ID: 19422481
    [No Abstract]   [Full Text] [Related]  

  • 3. Tongue hyperpigmentation during interferon therapy.
    Karabay O; Goksugur N; Ogutlu A
    J Dermatol; 2011 Mar; 38(3):290-1. PubMed ID: 21342236
    [No Abstract]   [Full Text] [Related]  

  • 4. Tongue hyperpigmentation during interferon-alpha and ribavirin therapy.
    Aguayo-Leiva I; Pérez B; Salguero I; Jaén P
    Eur J Dermatol; 2009; 19(3):291-2. PubMed ID: 19286489
    [No Abstract]   [Full Text] [Related]  

  • 5. Lingual hyperpigmentation with pegylated interferon and ribavirin therapy in patients with chronic hepatitis C.
    Sood A; Midha V; Bansal M; Goyal A; Sharma N
    Indian J Gastroenterol; 2006; 25(6):324. PubMed ID: 17264447
    [No Abstract]   [Full Text] [Related]  

  • 6. Tongue hyperpigmentation in a caucasian patient coinfected with HIV and hepatitis C during peginterferon alfa-2b and ribavirin therapy.
    Torres HA; Bull L; Arduino RC; Barnett BJ
    Am J Gastroenterol; 2007 Jun; 102(6):1334-5. PubMed ID: 17531028
    [No Abstract]   [Full Text] [Related]  

  • 7. Tongue hyperpigmentation during hepatitis C treatment.
    Bachmeyer C; Pellen JC
    CMAJ; 2012 Sep; 184(13):1498. PubMed ID: 22451683
    [No Abstract]   [Full Text] [Related]  

  • 8. Iatrogenic hyperpigmentation in chronically infected hepatitis C patients treated with pegylated interferon and ribavirin.
    Lin J; Lott JP; Amorosa VK; Kovarik CL
    J Am Acad Dermatol; 2009 May; 60(5):882-3. PubMed ID: 19389538
    [No Abstract]   [Full Text] [Related]  

  • 9. Lingual hyperpigmentation from pegylated interferon and ribavirin treatment of hepatitis C.
    Farshidi D; Chiu MW
    J Am Acad Dermatol; 2010 Jan; 62(1):164-165. PubMed ID: 20082904
    [No Abstract]   [Full Text] [Related]  

  • 10. Tongue hyperpigmentation resulting from peginterferon alfa-2b and ribavirin treatment in a patient with chronic hepatitis C.
    Ghosh S; Duseja A; Dhiman RK; Chawla YK
    Dig Dis Sci; 2012 Mar; 57(3):820-1. PubMed ID: 21948358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lingual hyperpigmentation in a patient with chronic infection].
    López Peláez MV; González Díaz P; Téllez Molina MJ; Vergas García J
    Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):264-5. PubMed ID: 23260387
    [No Abstract]   [Full Text] [Related]  

  • 12. Tongue hyperpigmentation resulting from peginterferon alfa and ribavirin combination therapy: a case report.
    de Moraes PC; Noce CW; Thomaz LA; Mautoni MC; Corrêa ME
    J Am Dent Assoc; 2009 Nov; 140(11):1377-9. PubMed ID: 19884395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection.
    Willems M; Munte K; Vrolijk JM; Den Hollander JC; Böhm M; Kemmeren MH; De Man RA; Brouwer JT
    Br J Dermatol; 2003 Aug; 149(2):390-4. PubMed ID: 12932249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral hyperpigmentation associated with interferon-alpha and ribavirin therapy for hepatitis C virus infection.
    Marcoval J; Notario J; Martín C; Gómez S
    Actas Dermosifiliogr; 2014 Mar; 105(2):211-2. PubMed ID: 23623282
    [No Abstract]   [Full Text] [Related]  

  • 15. Tongue hyperpigmentation during PEG-interferon-alfa/ribavirin therapy in a non-Caucasian patient with chronic hepatitis C: a case report and review of the literature.
    Mlika RB; Kerkeni N; Marrak H; Fenniche S; Mokhtar I; Debbiche A
    Int J Dermatol; 2013 May; 52(5):643-4. PubMed ID: 23046405
    [No Abstract]   [Full Text] [Related]  

  • 16. Peginterferon and ribavirin for hepatitis C.
    Ben Salem C; Hmouda H; Bouraoui K
    N Engl J Med; 2007 Mar; 356(12):1270; author reply 1271. PubMed ID: 17380578
    [No Abstract]   [Full Text] [Related]  

  • 17. Face skin hyperpigmentation during pegylated interferon and ribavirin therapy.
    Yaşar B; Yaşar Ş; Güneş P
    Turk J Gastroenterol; 2015 Mar; 26(2):189-90. PubMed ID: 25835121
    [No Abstract]   [Full Text] [Related]  

  • 18. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
    Rogers CJ; Romagosa R; Vincek V
    J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acute pancreatitis during treatment for chronic viral hepatitis C].
    Kabbaj N; Sentissi S; Guedira MM; Mohammadi M; Benaïssa A; Amrani N
    Gastroenterol Clin Biol; 2008 Mar; 32(3):232-3. PubMed ID: 18378105
    [No Abstract]   [Full Text] [Related]  

  • 20. Pernicious anemia during peginterferon-alpha2b plus ribavirin therapy for chronic hepatitis C.
    Musialik J; Petelenz M; Błoñska-Fajfrowska B; Hartleb M
    Eur J Gastroenterol Hepatol; 2009 May; 21(5):593-4. PubMed ID: 19194303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.